Absorption and Bioavailability of Captopril in Mice and Rats After Administration by Gavage and in the Diet
- 1 August 1981
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 70 (8), 885-888
- https://doi.org/10.1002/jps.2600700813
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Gas chromatography/selected ion monitoring mass spectrometric determination of captopril in human bloodAnalytical Chemistry, 1980
- Disposition of captopril in normal subjectsClinical Pharmacology & Therapeutics, 1980
- Thin-Layer Radiochromatographic Determination of Captopril (SQ 14,225) and its Disulfide Dimer Metabolite in BloodJournal of Liquid Chromatography, 1980
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Comparative absorption following the administration of a drug to rats by oral gavage and incorporation in the dietToxicology and Applied Pharmacology, 1978
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- An improved scintillation cocktail of high-solubilizing powerAnalytical Biochemistry, 1973
- PREDICTIVE DRUG TOXICITY - ASSESSMENT OF DRUG SAFETY BEFORE HUMAN USE1968